Rankings
▼
Calendar
LONA
LeonaBio, Inc.
$26M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$479,000
Operating Income
-$64M
Net Income
-$55M
EPS (Diluted)
$-14.90
Cash Flow
Operating Cash Flow
-$43M
Free Cash Flow
-$45M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$332M
Total Liabilities
$11M
Stockholders' Equity
$321M
Cash & Equivalents
$111M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$479,000
-$2M
+76.0%
Operating Income
-$64M
-$20M
-220.2%
Net Income
-$55M
-$20M
-174.9%
← Q4 2020
All Quarters
Q1 2021 →
LONA FY 2021 Earnings — LeonaBio, Inc. Revenue & Financial Results | Market Cap Arena